Cholecystokinin-B/gastrin-receptor binding peptides (Philipps University)

N/A

Report date: 2022/02/18 15:23:16

Base Information

Drug NameCholecystokinin-B/gastrin-receptor binding peptides (Philipps University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCholecystokinin A receptor agonistsCholecystokinin B receptor agonists
TargetsCholecystokinin A receptorCholecystokinin B receptor
Therapy Area/IndicationsThyroid Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPhilipps-Universität Marburg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhilipps-Universität Marburg
Active IndicationsN/A
Inactive IndicationsThyroid Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A